Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cysteine-rich secretory protein 2 (CRISP2) is a member of the CRISP family, encoding an intracellular protein highly expressed in the male reproductive tract, specifically within the testis and incorporated during spermatogenesis into the sperm head and tail[1][7]. It functions in the regulation of sperm motility and the acrosome reaction required for oocyte penetration during fertilization[1][7]. CRISP2 is structurally defined by a CAP domain responsible for cell-cell adhesion and steroid binding, and a CRISP domain implicated in ion channel regulation—most notably modulating calcium flux through ryanodine receptors and interacting with the sperm-specific CATSPER calcium channel[1][3]. Decreased or mutated CRISP2 is linked to male infertility, and it exhibits variable expression across mammalian species. In cancer biology, CRISP2 is classified as a cancer-testis antigen, with restricted expression that has prompted investigation as a biomarker, but has not yet been leveraged in targeted therapy or diagnostic applications[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteine-rich secretory protein 2 (CRISP2).